NEPHROS, INC. Leveraged Lease Investment
NEPHROS, INC. (NEPH) had Leveraged Lease Investment of $92.00 thousand as of 2016-12-31, per its 10-Q filed 2017-05-09.
Discontinued › Notes › and Other Assets
us-gaap:LeveragedLeaseInvestment · last filed 2017-05-09
- 2016-12-31: Leveraged Lease Investment $92.00K.
- 2016-09-30: Leveraged Lease Investment $92.00K.
- 2016-06-30: Leveraged Lease Investment $92.00K.
- 2016-03-31: Leveraged Lease Investment $92.00K.
| Period end | Leveraged Lease Investment |
|---|---|
| 2016-12-31 | $92.00K 10-Q · filed 2017-05-09 |
| 2016-09-30 | $92.00K 10-Q · filed 2016-11-10 |
| 2016-06-30 | $92.00K 10-Q · filed 2016-08-08 |
| 2016-03-31 | $92.00K 10-Q · filed 2016-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |